Revolution Medicines Inc Warrant Exp 12/17/202
Institutional coverage
18 13F filers hold $RVMDW.
13F holders
18
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
1 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 18 · Source: 13F-HR01
Oarsman Capital, Inc.
0.02% of portfolio
3,838,024 sh
02
Puzo Michael J
0.02% of portfolio
1,807,964 sh
03
Commerce Bank
—
1,580,345 sh
04
Signature Estate & Investment Advisors LLC
0.02% of portfolio
583,615 sh
05
Narus Financial Partners, LLC
0.01% of portfolio
517,685 sh
06
Partners Value Investments L.P.
—
500,000 sh
07
Cura Wealth Advisors, LLC
0.67% of portfolio
450,000 sh
08
Soros Capital Management LLC
0.03% of portfolio
364,824 sh
09
Nepsis Inc.
—
150,000 sh
10
Ferguson Wellman Capital Management, Inc.
—
120,085 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $RVMDW in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $RVMDW in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 13:16 UTC.